Answers are grounded in this paper and cite their sources.
Calcium carbonate (CaCO3) micro- and nanoparticles are biocompatible, biodegradable and pH-responsive carriers, but as free suspensions, they aggregate in biological fluids and migrate from the site of administration. A hydrogel matrix prevents both by separating the particles and retaining them locally. The carbonate filler provides the hydrogel with an acid-responsive release profile and mechanical reinforcement, while the released calcium ions confer intrinsic biological activity. This review first relates the synthesis conditions and polymorphic composition of CaCO3 (calcite, aragonite, vaterite and the amorphous phase) to particle stability, dissolution rate and bioactivity. It then considers three roles of the carbonate component in composites: a drug carrier, a source of Ca2+ for ionotropic cross-linking of polymer matrices, and a therapeutically active agent. Integration routes are compared, from mixing of pre-formed particles to internal gelation, in which the dissolving particles release the ions that form the matrix. Release of the active substance proceeds in two consecutive stages: its liberation from the dissolving particle and its diffusion through the polymer network. The rate-limiting stage depends on the acidity of the medium. Bone tissue regeneration and wound healing are the most extensively studied applications, whereas oncology, hemostatic materials and oral delivery remain less explored. Stabilization of metastable polymorphs, reproducible synthesis and long-term safety data are identified as key requirements for clinical translation.
No takes yet. Share an insight, caveat, or question.
Popova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: